4.6 Article

Use of the GRP1 PH domain as a tool to measure the relative levels of PtdIns(3,4,5)P-3 through a protein-lipid overlay approach

Journal

JOURNAL OF LIPID RESEARCH
Volume 48, Issue 3, Pages 726-732

Publisher

ELSEVIER
DOI: 10.1194/jlr.D600038-JLR200

Keywords

phosphatidylinositol (3,4,5) -trisphosphate; neomycin; phosphoinositide 3-kinase; general receptor for phosphoinositides-1; protein-lipid overlay; neutrophil; p110 gamma; Ras

Funding

  1. BBSRC [BB/D013593/1] Funding Source: UKRI
  2. MRC [G9403619] Funding Source: UKRI
  3. Biotechnology and Biological Sciences Research Council [BB/D013593/1] Funding Source: researchfish
  4. Medical Research Council [G9403619] Funding Source: researchfish

Ask authors/readers for more resources

We describe a novel approach to the relative quantification of phosphatidylinositol (3,4,5)-trisphosphate [Ptdlns(3,4,5)P-3] and its application to measure, in neutrophils, the activation of phosphoinositicle 3-kinase (PI3K). This protein-lipid overlay-based assay allowed us to confirm and extend the observations, first, that N-formyl-methionyl-leucyl-phenylaianine (fMLP) stimulation of primed human neutrophils leads to a transient and biphasic increase in Ptdlns(3,4,5)P-3 levels and, second, that the ability of fMLP to stimulate Ptdlns(3,4,5)P-3 accumulation in neutrophils isolated from mice carrying a Ras-insensitive ('DASAA') knock-in of PI3K gamma (p110 gamma(DASAA/DASAA)) is substantially dependent on the Ras binding domain of PI3K gamma.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available